Medicare is likely to pay for anticancer drugs
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7346.1118/b (Published 11 May 2002) Cite this as: BMJ 2002;324:1118
- Fred Charatan
- Florida
The US Congress looks set to provide cover for anticancer drugs under Medicare, the federal health insurance programme for Americans aged over 65.
A bill currently before the house looks likely to be passed this year. According to law makers and lobbyists, this would be a first step towards a prescription drug benefit for Medicare subscribers.
A compromise on drugs to treat cancer would help many elderly Americans who must often choose between expensive prescription drugs and groceries. More than a fifth of the 40 million Medicare beneficiaries …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.